Mainz, Germany

Stephanie Erbar

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 11.5

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Stephanie Erbar

Introduction

Stephanie Erbar, an accomplished inventor based in Mainz, Germany, has made significant contributions to the field of RNA delivery systems. With two patents to her name, her work focuses on enhancing the efficacy of RNA formulations for therapeutic applications.

Latest Patents

Stephanie's latest patents showcase her expertise in developing formulations for the administration of RNA. These inventions, which concern polyplex formulations designed for the delivery of RNA to target organs or cells through parenteral administration, particularly via intramuscular injection, exhibit her commitment to innovation in the pharmaceutical field. The formulations consist of polyplex particles created from single-stranded RNA and polyalkyleneimine, adding a novel dimension to RNA therapeutics. Importantly, these formulations may encapsulate RNA that encodes pharmaceutically active proteins, broadening the possibilities for medical intervention. Moreover, her inventions also encompass the manufacturing processes for pharmaceutical products derived from these RNA polyplex formulations, including steps like sterile filtration, freezing, and dehydration.

Career Highlights

Throughout her career, Stephanie has had the opportunity to collaborate with leading companies in the industry, including BioNTech SE and Tron - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH. Her work at these institutions emphasizes her role in pushing boundaries within the domain of RNA research and application.

Collaborations

In her professional journey, Stephanie has worked alongside esteemed colleagues, such as Ugur Sahin and Heinrich Haas. Their collaborations reflect a shared commitment to advancing the field of biotechnology and developing impactful solutions for medical treatments.

Conclusion

Stephanie Erbar's innovative contributions to RNA formulation and delivery systems underscore her significant role as an inventor in the medical field. Her patents not only enhance pharmaceutical applications but also pave the way for future advancements in gene therapy and RNA-based treatments. With her continued dedication and expertise, Stephanie is poised to make further strides in the world of scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…